Skip to main content
Erschienen in: Lasers in Medical Science 2/2019

19.07.2018 | Brief Report

Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm

verfasst von: Gökhan Demir, Özgür Artunay, Mehmet Emin Sucu, Ali Demircan, Dilek Yaşa, Cengiz Alagöz, Mevlüt Celal Öcal

Erschienen in: Lasers in Medical Science | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Macular telangiectasia type 2 (Mac Tel 2) is a bilateral disease of unknown cause with characteristic changes of the retinal vasculature. To the best of our knowledge, we could not find any reported cases of Mac Tel 2 with retinal arterial macroaneurysm (RAM). Our aim is to report a case of Mac Tel 2 with RAM.
Literatur
1.
Zurück zum Zitat Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100:1536–1546CrossRefPubMed Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100:1536–1546CrossRefPubMed
2.
Zurück zum Zitat Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124:450–460CrossRefPubMed Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124:450–460CrossRefPubMed
3.
Zurück zum Zitat Gass JD, Oyakawa RT (1982) Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 100:769–780CrossRefPubMed Gass JD, Oyakawa RT (1982) Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 100:769–780CrossRefPubMed
4.
Zurück zum Zitat Tonotsuka T, Mai M, Saito K, Iijima H (2003) Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol 47:498–502CrossRefPubMed Tonotsuka T, Mai M, Saito K, Iijima H (2003) Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol 47:498–502CrossRefPubMed
5.
Zurück zum Zitat Rabb MF, Gagliano DA, Teske MP (1988) Retinal arterial macroaneurysms. Surv Ophthalmol 33:73–96CrossRefPubMed Rabb MF, Gagliano DA, Teske MP (1988) Retinal arterial macroaneurysms. Surv Ophthalmol 33:73–96CrossRefPubMed
6.
Zurück zum Zitat Clemons TE, Gillies MC, Chew EY et al (2008) The national eye institute visual function questionnaire in the macular telangiectasia (MacTel) project. Invest Ophthalmol Vis Sci 49:4340–4346CrossRefPubMedPubMedCentral Clemons TE, Gillies MC, Chew EY et al (2008) The national eye institute visual function questionnaire in the macular telangiectasia (MacTel) project. Invest Ophthalmol Vis Sci 49:4340–4346CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Charbel Issa P, Finger RP, Kruse K et al (2011) Monthly ranibizumab for non-proliferative macular telangiectasia type 2: a 12-month prospective study. Am J Ophthalmol 151:876–886CrossRefPubMed Charbel Issa P, Finger RP, Kruse K et al (2011) Monthly ranibizumab for non-proliferative macular telangiectasia type 2: a 12-month prospective study. Am J Ophthalmol 151:876–886CrossRefPubMed
8.
Zurück zum Zitat Park DW, Schatz H, McDonald HR et al (1997) Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 104:1838–1846CrossRefPubMed Park DW, Schatz H, McDonald HR et al (1997) Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 104:1838–1846CrossRefPubMed
9.
Zurück zum Zitat De Lahitte GD, Cohen SY, Gaudric A (2004) Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired parafoveal telangiectasis without subretinal neovascularization. Am J Ophthalmol 138:892–894CrossRefPubMed De Lahitte GD, Cohen SY, Gaudric A (2004) Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired parafoveal telangiectasis without subretinal neovascularization. Am J Ophthalmol 138:892–894CrossRefPubMed
10.
Zurück zum Zitat Moon SJ, Berger AS, Tolentino MJ et al (2007) Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surg Lasers Imaging 38:164e6 Moon SJ, Berger AS, Tolentino MJ et al (2007) Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surg Lasers Imaging 38:164e6
11.
Zurück zum Zitat Moosavi RA, Fong KC, Chopdar A (2006) Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond) 20:1011–1020CrossRef Moosavi RA, Fong KC, Chopdar A (2006) Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond) 20:1011–1020CrossRef
12.
Zurück zum Zitat Tsujikawa A, Sakamoto A, Ota M et al (2009) Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography. Retina 29:782–792CrossRefPubMed Tsujikawa A, Sakamoto A, Ota M et al (2009) Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography. Retina 29:782–792CrossRefPubMed
13.
Zurück zum Zitat Cahuzac A, Scemama C, Mauget-Faÿsse M et al (2016) Retinal arterial macroaneurysms: clinical, angiographic, and tomographic description and therapeutic management of a series of 14 cases. Eur J Ophthalmol 26:36–43CrossRefPubMed Cahuzac A, Scemama C, Mauget-Faÿsse M et al (2016) Retinal arterial macroaneurysms: clinical, angiographic, and tomographic description and therapeutic management of a series of 14 cases. Eur J Ophthalmol 26:36–43CrossRefPubMed
14.
15.
Zurück zum Zitat Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K et al (2001) Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50:444–454CrossRefPubMed Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K et al (2001) Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50:444–454CrossRefPubMed
16.
Zurück zum Zitat Erol MK, Dogan B, Coban DT, Toslak D, Cengiz A, Ozel D (2015) Intravitreal Ranibizumab therapy for retinal arterial macroaneurysm. Int J Clin Exp Med 8(7):11572–11578PubMedPubMedCentral Erol MK, Dogan B, Coban DT, Toslak D, Cengiz A, Ozel D (2015) Intravitreal Ranibizumab therapy for retinal arterial macroaneurysm. Int J Clin Exp Med 8(7):11572–11578PubMedPubMedCentral
17.
Zurück zum Zitat Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella AP, Nucci P (2013) Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol 155:287–294CrossRefPubMed Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella AP, Nucci P (2013) Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol 155:287–294CrossRefPubMed
Metadaten
Titel
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm
verfasst von
Gökhan Demir
Özgür Artunay
Mehmet Emin Sucu
Ali Demircan
Dilek Yaşa
Cengiz Alagöz
Mevlüt Celal Öcal
Publikationsdatum
19.07.2018
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 2/2019
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-018-2587-5

Weitere Artikel der Ausgabe 2/2019

Lasers in Medical Science 2/2019 Zur Ausgabe